GeoVax Labs Inc (GOVX)

GeoVax Labs Inc (GOVX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.9M; returns 1 day -3.1%, 1 week -13.6%, 1 year -98.5%.

GeoVax Labs Inc. is a clinical-stage biotechnology company focused on developing human vaccines and immunotherapies for infectious diseases and cancer using its proprietary modified vaccinia Ankara (MVA) viral vector platform.

Groups GOVX belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Life Sciences
• Infectious Diseases
• COVID-19
• Oncology
• Cancer Therapeutics
• Gene Therapy
• Immunotherapy
• Clinical Stage

GOVX financial model: income statement, cash flow and balance sheet